BRAF and melanoma: Although BRAF inhibitors in combination with MEK inhibitors are useful for the treatment of BRAFV600-mutant advanced melanoma, the population of BRAFV600-mutant advanced melanoma is limited, particularly in the Japanese population, which contains large populations with acral lentiginous melanoma and mucosal melanoma (5, 6).